Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03139721 · ClinicalTrials.gov registry record

Medtronic HAMMOCK Post Approval Study

A clinical trial of Heart Valve Diseases, sponsored by Medtronic Cardiac Surgery.

Completed
Registry status
122
Enrollment target
7
Study locations

NCT03139721 is a study of Heart Valve Diseases that has completed, run by Medtronic Cardiac Surgery. The registered enrollment target is 122 participants, below the 1,075-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (89% lower). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03139721, a study of Heart Valve Diseases, has completed, sponsored by Medtronic Cardiac Surgery.

COMPLETED
Registry status
122 participants
Enrollment target
7
Study locations

Study Summary

This study is being conducted to satisfy the post-CE approval requirement.

Conditions Studied

Interventions

  • DEVICE Mosaic model 305, model 310, and ultra model 305

Study Locations (7)

Other

  • Universitätsklinikum Hamburg-Eppendorf - Hamburg
  • Deutsches Herzzentrum München Klinik an der TU München - München
  • Institute of Cardiology in Warsaw - Warsaw

Indiana

  • Franciscan Saint Francis Health - Indianapolis

Ohio

  • ProMedica Toledo Hospital - Toledo

Washington

  • Saint Joseph Medical Center - Tacoma

Wisconsin

  • Bellin Memorial Hospital - Green Bay

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2017-06-19
Est. Completion 2021-06-21

Sponsor

Medtronic Cardiac Surgery

7 total trials

What the Registry Record Tells You About NCT03139721

The ClinicalTrials.gov registry entry for NCT03139721 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,075-participant average among 13 other Heart Valve Diseases trials with a reported enrollment target (89% lower). The listed sponsor is Medtronic Cardiac Surgery, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Valve Diseases appearing as the primary indexed condition, and to 1 intervention - of which Mosaic model 305, model 310, and ultra model 305 is the first listed.

NCT03139721 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Other, Indiana, Ohio.

Frequently Asked Questions

What is clinical trial NCT03139721 about?

NCT03139721 is a clinical study titled "Medtronic HAMMOCK Post Approval Study". This study is being conducted to satisfy the post-CE approval requirement.

What is the current status of trial NCT03139721?

This trial is currently completed. The enrollment target is 122 participants. The study started on 2017-06-19. Estimated completion is 2021-06-21.

What conditions does trial NCT03139721 study?

This clinical trial studies the following conditions: Heart Valve Diseases.

What interventions are being tested in trial NCT03139721?

The interventions under investigation include: Mosaic model 305, model 310, and ultra model 305 (DEVICE).

Who is sponsoring clinical trial NCT03139721?

This trial is sponsored by Medtronic Cardiac Surgery, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03139721 being conducted?

This trial has 7 study locations across Indiana, Ohio, Washington, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Valve Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.